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Differentiation of preadipocytes into adipocytes is controlled by various transcription factors.
Recently, the pro-adipogenic function of XBP1, a transcription factor upregulated by endoplasmic
reticulum stress, has been reported. In this study, we demonstrated that XBP1 suppresses the
expression of Wnt10b, an anti-adipogenic Wnt, during the differentiation of 3T3-L1 preadipocytes.
The expression pattern of XBP1 was reciprocal to that of Wnt10b during the early stage of adipogen-
esis. The intracellular protein levels of b-catenin were negatively regulated by XBP1. Direct binding
of XBP1 to the Wnt10b promoter and the subsequent decrease of the b-catenin signalling pathway
represent a novel adipogenic differentiation mechanism.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Adipose tissue is a primary metabolic organ that is important
for energy homeostasis and insulin sensitivity, and the excess
deposition of adipose tissue is an established risk factor for many
pathologic conditions [1]. Adipogenesis, the molecular events
underlying the expansion of adipose tissue, is the process by which
ﬁbroblast-like preadipocytes differentiate into adipocytes.
X-box binding protein 1 (XBP1) is an important transcription
factor of the unfolded protein response (UPR). During the UPR,
XBP1 mRNA is converted to its active form, XBP1s, and it then in-
creases the expression of UPR-associated genes involved in protein
folding and endoplasmic reticulum biogenesis [2]. XBP1 also plays
various roles in many UPR-unrelated biological processes. XBP1 in-
duces the differentiation of many cells, e.g., plasma cells and hepa-
tocytes [3,4], and it also plays a crucial role in glucose metabolism,
inﬂammation, and insulin function [5]. Recently, a few reports dem-
onstrated the role of XBP1 in the regulation of adipogenesis. For
example, XBP1 is induced during adipogenesis [6,7], and it plays a
key role in adipocyte differentiation by the induction of CCAAT/en-hancer-binding protein a (C/EBPa) in 3T3-L1 cells [8]. In contrast,
Han et al. reported that IRE1a did not alter adipocyte differentiation
in 3T3-L1 cells [9].
Wnts are secreted glycoproteins that activate the b-catenin-
mediated signalling pathway, which controls a myriad of biological
processes [10]. In preadipocytes, Wnt/b-catenin signalling main-
tains the cells in an undifferentiated state primarily by suppressing
adipogenic transcription factors C/EBPa and peroxisome prolifera-
tor-activated receptor c (PPARc). Disruption of Wnt signalling also
causes myoblasts to transdifferentiate into adipocytes in vitro,
indicating the importance of Wnt/b-catenin signalling in adipocyte
differentiation [11,12]. Of the 19 Wnt ligands found in humans and
mice, Wnt10b is a major Wnt ligand in preadipocytes and its levels
decline rapidly after the induction of differentiation [11], and the
overexpression of Wnt10b in 3T3-L1 cells stabilizes b-catenin
and blocks adipogenesis, suggesting it is a molecular switch that
governs adipogenesis [13]. The association of Wnt10b with obesity
has been also suggested [14].
Although the signalling pathways downstream of Wnt10b that
regulate adipogenesis are being deﬁned, little is known about the
mechanisms involved in the control of Wnt10b expression. Re-
cently, Chung et al. reported that C/EBPb downregulates Wnt10b
expression during adipogenesis [15]. Because XBP1 was strongly
induced by C/EBPb in 3T3-L1 cells [8], here, we examined whether
XBP1 acts as an upstream regulator of Wnt10b during
adipogenesis.
Table 1
Primers used for real-time PCR.
Name Primer Sequences (50–30) Size (bp) Gene ID
Sense Antisense
36B4 GCTCCAAGCAGATGCAGCA CCGGATGTGAGGCAGCAG 143 NM_007475
mAdiponectin TGTGTATCGCTCAGCGTTCAGTGT AGAGAACGGCCTTGTCCTTCTTGA 224 NM_007678
mC/EBPa AGCTTACAACAGGCCAGGTTTCCT TTCAAGTTCCTTCAGCAACAGCGG 213 NM_007678
mFzd2 TCATCTTTCTGTCCGGCTGCTACA AGCTGGCCATGCTGAAGAAGTAGA 186 NM_020510
mLRP5 TGAAGGAATGGCTGTGGACTGGAT TGTCAAGGTCTCTCCACACAAGCA 125 NM_008513
mWnt1 GGTTTCTACTACGTTGCTACTGG GGAATCCGTCAACAGGTTCGT 121 NM_021279
mWnt10b TGGCTGTAACCACGACATGGACTT CTGACGTTCCATGGCATTTGCACT 170 NM_011718
mWnt4 CTCAAAGGCCTGATCCAGAG TCACAGCCACACTTCTCCAG 281 NM_009523
mWnt5a ACTGGCAGGACTTTCTCAAGGACA GCCTATTTGCATCACCCTGCCAAA 181 NM_009524
mWnt5b CCCCAGGCCAGAGAAAGC CCTCCCCGATGTAGGACAT 60 NM_009525
mWnt6 TGTCAGTTCCAGTTCCGTTTCCGA ACACGAAAGCTGTCTCTCGGATGT 100 NM_009526
mXBP1s CTGAGGTCCGCAGCAGGT TGTCAGAGTCCATGGGAAGA 66 NM_013842
mXBP1t AGCAGCAAGTGGTGGATTTGGAAG AAGAGGCAACAGTGTCAGAGTCCA 299 NM_013842
mb-catenin TGCAGCTTCTGGGTTCCGATGATA AGATGGCAGGCTCAGTGATGTCTT 180 NM_001165902
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2.1. Cell culture and adipocytes differentiation
The murine 3T3-L1 preadipocytes (American Type Culture Col-
lection, Manassas, VA, USA) were maintained in high-glucose
(400 mg/dl) DMEM containing 10% newborn calf serum (Gibco,
Green Island, NY, USA). Two days after reaching conﬂuence (day
0), the cells were subjected to adipogenic differentiation for 2 days
in the medium containing 3-isobutyl-1-methylxanthine (0.5 mM,
Sigma, St. Louis, MO, USA), dexamethasone (1 lM, Sigma), and
insulin (167 nM, Sigma). Then the cells were cultured for 2 days
in the DMEM with 10% FBS and insulin (167 nM), and thereafter
the medium was changed to the DMEM/10% FBS until day 8.
2.2. Genetic manipulation of XBP1
XBP1 knockdown cells were prepared using retroviral vectors
expressing shRNA targeting mouse XBP1 (SFGneo-iXBP1, from
Prof. Glimcher, Cornell Medical College, New York, NY, USA). Viral
supernatant was prepared as described [16] and was used to trans-
duce. Brieﬂy, 293T cells were transfected with the viral vectors
using Lipofectamin 2000 (Invitrogen, Carlsbad, CA, USA). After
48 h, virus-containing medium was collected and passed through
a 0.22-lm ﬁlter. For infection, ﬁlter-sterilized Polybrene (hexadi-
methrine bromide; 8 lg/ml, Sigma) was added to the virus-loaded
medium and applied to proliferating cells for 2 days. Uninfected
cells were removed by culturing in the presence of G418 (1 mg/
ml). To make XBP1s-overexpressing cells, recombinant plasmids
expressing mouse XBP1s (pcDNA3.1-mXBP1s, from Prof. Glimcher)
were transfected using Lipofectamin 2000, and selected with G418.
2.3. Oil-red O staining
Cells were washed twice with PBS, ﬁxed with 10% formalin in
distilled water (DW) for 10 min. After being rinsed with DW, cells
were incubated for 10 min with 0.3% of Oil-red O (Sigma). The
monolayer was then extensively washed with DW, and stained
cells were mounted for microscopic examination (Leica micro-
scope, Wetzlar, Germany).
2.4. RNA isolation and real-time PCR
Total RNA was extracted from the cultures using Trizol Reagent
(Invitrogen), and cDNA was synthesized using PrimeScript™ RT kit
(Takara, Shiga, Japan). The quantitative real-time PCR analysis was
performed on at least three independent RNA samples using ABI7300 thermal cycler (Applied Biosystems, Foster City, CA, USA)
with SYBR Green Q-PCR Master Mix (Takara). The relative amount
of mRNAs was calculated using the DDCt method with the 36B4
mRNA as an internal control. The primer sequences for real-time
PCR are listed in Table 1.
2.5. Preparation of cytoplasmic fraction
Cells were washed in PBS and scraped in 10 mM Tris–HCl (pH
7.4) containing 140 mM NaCl, 5 mM EDTA, 2 mM dithiothreitol,
0.5 mM PMSF, 2 lg/ml aprotinin, and 1 lg/ml leupeptin. Cells were
lysed by 30 strokes in Potter–Elvehjem homogenizer (Wheaton
Scientiﬁc, Millville, NJ, USA) at 4 C. The lysates were centrifuged
at 500g for 10 min, and the cleared lysates were subject to ultra-
centrifugation at 100000g for 90 min at 4 C. The supernatants
were collected as the cytoplasmic fraction.
2.6. Immunoblot analysis
Cells were lysed in RIPA buffer and spun for 30 min at 16000g.
Thirty micrograms of protein were separated by 10% SDS–PAGE
and transferred onto a nitrocellulose membrane (Schleicher &
Schell, Dassel, Germany). The membranes were blocked with 5%
non-fat milk and incubated overnight at 4 C with the mouse anti-
sera against adiponectin (1:1000; Alexis, Farmingdale, NY, USA), b-
catenin (1:500; BD Bioscience, San Jose, CA, USA) and b-actin
(1:500; Sigma), and rabbit antisera against XBP1 (1:200; Biovision,
Mountain View, CA, USA) and C/EBPa (1:500; Santa Cruz, Santa
Cruz, CA, USA). Antibody binding was detected using horseradish
peroxidase-conjugated anti-rabbit or anti-mouse IgG (1:2,000; Sig-
ma) and the immunoreactive bands were visualized with ECL
method (Amersham Pharmacia Biotech, Little Chalfont, UK). In
some experiments, the density of speciﬁc bands was measured
and normalized with the control band.
2.7. Promoter assay
3T3-L1 preadipocytes were seeded into 24-well plates at a den-
sity of 2  104/well. Reporter plasmids (100 ng) were transfected
with effector or empty vectors (0.5 or 1 lg). To normalize transfec-
tion efﬁciency, the Renilla luciferase-expressing plasmid (pRL-TK-
luc; 10 ng) was cotransfected as internal control. After 48 h, cells
were lysed in passive lysis buffer and the luciferase activities of
both reporters were measured using a dual luciferase assay kit
(Promega, Madison, WI, USA). For Wnt10b promoter assay, we
used mouse Wnt10b promoter construct [mWnt10b (2675)-
Luc] which carry a DNA fragment of Wnt10b (2675 to 135 bp)
Fig. 1. XBP1 enhances adipogenic differentiation of 3T3-L1 cells. Wild-type (CON)
or XBP1 knockdown (XBP1-KD) 3T3-L1 preadipocytes were differentiated for
8 days, and total RNAs and proteins were prepared at the indicated times. (A) Real-
time PCR analysis of total (XBP1t) and spliced form (XBP1s) of XBP1 mRNA in wild-
type 3T3-L1 cells (⁄p < 0.05, compared to day 0). (B) Oil-red O staining at 8 days
(magniﬁcation 100). The images shown are representative of 3 experiments. (C)
Real-time PCR (upper) and immunoblot (lower) analyses of C/EBPa and adiponec-
tin. Beta-actin was used as loading control. In data from real-time PCR, mRNA level
at day 0 of 3T3-L1 cells was set to 1, and the other values were normalized and
represented as the mean ± S.E.M. of 3 independent experiments (⁄P < 0.05, com-
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University, Seoul, Korea). For monitoring of Wnt/b-catenin signal-
ling pathway, we used Super TOPFlash (Addgene Inc., Cambridge,
MA, USA) encoding seven copies of LEF/TCF binding sites linked
to ﬁreﬂy luciferase. Super FOPFlash (Addgene) which has mutated
LEF/TCF binding sites was used as negative control.
2.8. Chromatin immunoprecipitation (ChIP) assay
ChIP assay was performed according to the supplier’s protocol
(Millipore, Billerica, MA, USA). Brieﬂy, cells were differentiated
for the indicated times and crosslinked with formaldehyde, and
resuspended and sonicated to generate 200–1000 bp DNA frag-
ments. The fragmented chromatin samples were immunoprecipi-
tated with rabbit antisera against mouse XBP1 (5 lg, M-186X;
Santa Cruz), and were reverse-cross-linked, puriﬁed, and analyzed
by real-time PCR. Primers used for the amplicon (525 to 316 bp)
are: CCTAAGGTCTAGATCCGTCCT (forward), and GATCACGATT
AGCCCACTCCA (reverse). DNA samples immunoprecipitated with
rabbit IgG served as a negative control.
2.9. Statistical analysis
All values were expressed as mean ± S.E.M. from at least three
independent experiments. Data was analyzed using one- or two-
way ANOVA followed by Tukey’s Multiple Comparison Test. Statis-
tical analyses were performed using Graphpad Prism 5 for Win-
dows (Graphpad Prism Software Inc., La Jolla, CA, USA). In all
cases, statistical signiﬁcance was set at P < 0.05.
3. Results
3.1. XBP1s is a critical factor for 3T3-L1 adipogenesis
During the differentiation of 3T3-L1 preadipocytes, transcrip-
tion of both the total and spliced forms of XBP1 was increased in
a time-dependent manner (Fig. 1A). To examine the role of XBP1s
in adipogenesis, we prepared 3T3-L1 cells in which the expression
of XBP1 was knocked down (XBP1-KD), and adipogenic differenti-
ation was induced for 8 days. When we compared the degree of
adipocyte development using Oil Red O staining between control
and XBP1-KD cells at post-induction day 8, it was markedly re-
duced in XBP1-KD cells (Fig. 1B). Moreover, mRNA and protein
expression of the adipocyte markers C/EBPa and adiponectin was
signiﬁcantly decreased in XBP1-KD cells (Fig. 1C). These results
strongly suggest that XBP1s is necessary for the adipogenesis of
3T3-L1 cells.
3.2. XBP1s suppresses intracellular b-catenin levels
To investigate the molecular mechanism for the stimulation of
adipogenesis by XBP1s, we examined the Wnt/b-catenin signalling
pathway, which is a well-known regulatory mechanism of adipo-
genesis. First, we examined the cellular levels of b-catenin, a cen-
tral player in the Wnt/b-catenin signalling pathway. Consistent
with prior reports [17], the protein levels of b-catenin were signif-
icantly and time-dependently decreased immediately after hor-
monal induction in wild-type 3T3-L1 cells, whereas it was not
altered in XBP1-KD cells (Fig. 2A, left). When we normalized the
immunoreactive bands using densitometry (Fig. 2A, right), b-cate-
nin levels were dramatically decreased from day 1 in wild-type
cells; however, they were signiﬁcantly higher in XBP1-KD cells at
all times tested. Moreover, the forced expression of XBP1s in
3T3-L1 cells signiﬁcantly reduced b-catenin levels (Fig. 2B). How-
ever, b-catenin transcription was not affected by XBP1 (Fig. 2C).Thus, we hypothesize that XBP1s may suppress b-catenin signal-
ling through the inhibition of extracellular Wnt ligands.
3.3. XBP1s inhibits Wnt10b expression
Wnts bind to their cell-surface receptors and allow b-catenin to
escape from the destruction complex, and consequently accumu-
late and translocate to the nucleus. To identify which Wnts were
regulated by XBP1s, we examined the mRNA levels of 3 typical
anti-adipogenic (Wnt1, 10b, and 6) and 3 pro-adipogenic (Wnt4,
5a, and 5b) Wnts in XBP1-KD and control cells. Fig. 3A shows that
only Wnt10b, the most potent anti-adipogenic Wnt [11], was sig-
niﬁcantly increased by up to 2-fold following XBP1 knockdown.
Wnt10b is highly expressed in preadipocytes, and during the
early stage of adipogenic differentiation, the so-called critical per-
iod of differentiation, a rapid decrease of Wnt10b levels is required
for adipogenesis [18]. In our study, Wnt10b transcription declined
immediately after hormonal induction and reached its lowest levelpared to the CON).
Fig. 2. XBP1 suppresses intracellular b-catenin level during hormonal induction of adipogenesis. (A) Beta-catenin levels in the cytoplasmic fraction of wild-type (CON) and
XBP1-KD (KD) cells were measured using immunoblot analysis (left), and the results were expressed in b-catenin/b-actin ratio (right). The ratio at day 0 of CON was set to 1
(⁄P < 0.05, compared to the CON). (B) Immunoblot analysis of b-catenin in the cytoplasmic fraction of 3T3-L1 cells transfected with empty vector (EV) or expression vector
carrying XBP1s (XBP1s). The ratio at day 2 of CON was set to 1. Beta-actin was used as loading control (⁄P < 0.05, compared to the EV). (C) Real-time PCR analysis of b-catenin
in CON and KD cells. The mRNA level at day 0 of CON was set to 1. Data represent the mean ± S.E.M. of three independent experiments.
Fig. 3. XBP1 inhibits the expression of Wnt10b. (A) The mRNA levels of anti-adipogenic (1, 10b, and 6) or pro-adipogenic (4, 5a, and 5b) isoforms of Wnt were measured in
undifferentiated wild-type (CON) or XBP1-KD (KD) 3T3-L1 cells. (B) The mRNA level of Wnt10b was measured during the early adipogenesis in CON and KD cells. (C) Plotting
of mRNA levels of Wnt10b (d) and XBP1s (s) for 2 days after differentiation induction. All data represent the mean ± S.E.M. of three independent experiments. (⁄P < 0.05,
compared to the CON; #P < 0.05, compared to the 0 h of CON).
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levels were signiﬁcantly higher before induction and at 3 h after
(Fig. 3B). To examine the interrelationship between XBP1s and
Wnt10b, we plotted their mRNA levels for 2 days after induction,
and found that their expression patterns were the opposite of each
other (Fig. 3C). At 6 h, the mRNA levels of XBP1s reached a peak,
whilst Wnt10b declined to its lowest level.
3.4. Wnt10b is a direct target of XBP1s
Direct regulation of Wnt10b expression by XBP1s was exam-
ined using promoter and chromatin immunoprecipitation (ChIP)
analyses. Promoter assay was performed using a 2.5-Kb genomic
fragment of Wnt10b containing putative XBP1 binding sites(Fig. 4A). When we cotransfected the XBP1s expression vector
and Wnt10b promoter reporter into 3T3-L1 cells, Wnt10b pro-
moter activity was signiﬁcantly decreased by 50%, indicating the
regulation of Wnt10b transcriptional activity by XBP1s (Fig. 4B).
ChIP analysis also revealed that XBP1s directly bound to the
Wnt10b promoter before and at 6 and 12 h after induction
(Fig. 4C). Because the effects of Wnt are mediated through cell sur-
face Wnt receptors, we examined whether XBP1s affects the
expression of Frizzled (Fzd) and low-density lipoprotein-related
protein 5 (LPR5) during adipogenesis. Corresponding to previous
studies [19], the mRNA levels of Fzd declined rapidly from 3 h,
whilst those of LRP5 were steady and even increased after 24 h
in wild-type 3T3-L1 cells; however, the expression patterns of
these Wnt receptors were not affected by XBP1s during the ﬁrst
Fig. 4. XBP1 suppresses Wnt10b expression by directly binding to the promoter. (A) Schematic representation of mouse Wnt10b promoter construct used for promoter
assays. (B) Promoter assay was performed in 3T3-L1 cells, which were cotransfected with pGL2-Wnt10b reporter vector, and empty vector (EV) or full-length XBP1s-
expressing plasmids (XBP1s). Luciferase activity was assessed 48 h after the transfection (⁄P < 0.05, compared to the EV) (C) ChIP analysis. The precipitated chromatin was
analyzed by real-time PCR using primers spanning the putative XBP1s binding site within the Wnt10b promoter (–525 to –316 bp) (⁄P < 0.05, compared to the IgG). (D) Real-
time PCR analysis of Wnt receptors Frizzled (Fzd) and LRP5. All data represent the mean ± S.E.M. of three independent experiments.
Fig. 5. XBP1 downregulates the transcriptional activity of the b-catenin. (A) 3T3-L1 preadipocytes were cotransfected with Super TOPFlash, and empty vector (EV) or full-
length XBP1s-expressing plasmids (XBP1s) for 48 h. Super FOPFlash was used as negative control. Data represent the mean ± S.E.M. of three independent experiments
(⁄P < 0.05, compared to the EV). (B) Diagram of XBP1s-mediated Wnt10b regulation during adipogenic differentiation.
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induce adipogenesis through the transcriptional repression of
Wnt10b and the subsequent inhibition of the anti-adipogenic b-
catenin signalling pathway.
3.5. XBP1s antagonizes the b-catenin-TCF/LEF-mediated signalling
pathway
Upon Wnt ligand binding, b-catenin binds directly to T cell fac-
tor/lymphoid enhancer factor (TCF/LEF) and stimulates the tran-
scription of a variety of Wnt-responsive genes [20]. To explore
the possibility that XBP1s represses Wnt10b/b-catenin-mediated
transcriptional activity, we performed a reporter gene assay using
a promoter construct containing multiple TCF/LEF binding sites.
When XBP1s was co-expressed with the Super TOPFlash reporter
construct for 48 h, XBP1s signiﬁcantly downregulated TCF/LEFpromoter activity by approximately 50% (Fig. 5A, left). Super FOP-
Flash activity was not afftected by XBP1s (Fig. 5A, right). Thus, we
conclude that XBP1s may regulate b-catenin-induced transcrip-
tional activity by direct repression of Wnt10b expression.
4. Discussion
XBP1s, a key player in UPR activation, is upregulated during
lipogenesis [21], and UPR activation contributes to the adipogene-
sis of 3T3-L1 cells [6]. Anti-adipogenic Wnt signalling should also
be inhibited for the initiation of adipocyte differentiation [15].
On the basis of these ﬁndings, we examined the involvement of
XBP1s in Wnt/b-catenin signalling and provided evidence for the
ﬁrst time that XBP1s induces adipogenesis by antagonizing the b-
catenin-mediated anti-adipogenic signalling pathway during the
early stage of adipogenic differentiation of 3T3-L1 cells. XBP1s
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potent anti-adipogenic Wnt ligand, without affecting the expres-
sion of b-catenin or the Wnt receptors Fzd and LPR5. When com-
bined with a recent report showing the transcriptional repression
of Wnt10b by C/EBPb [15], our results suggest a new model for
the initiation of adipogenesis (Fig. 5B). Both C/EBPb and XBP1s
are upregulated in response to adipogenic induction, and C/EBPb
transactivates XBP1 transcription [10]. C/EBPb induces two pro-
adipogenic transcription factors PPARc and C/EBPa, and XBP1s also
increases C/EBPa [8]. Simultaneously with this pro-adipogenic
activity, C/EBPb and XBP1s also inhibit anti-adipogenic b-catenin
signaling by the suppression of Wnt10b expression, therefore
resulting in the potentiation of adipogenesis. C/EBPb also inhibits
b-catenin signalling by the direct interaction between b-catenin
and PPARc, which was induced by C/EBPb [26]. In addition,
Wnt10b/b-catenin prevents preadipocytes from adipogenic differ-
entiation by decreasing the expression of PPARc and C/EBPa. Taken
together, the adipogenic program is initiated and intensiﬁed syner-
gistically by two dual-function transcription factors, i.e., C/EBPb
and XBP1s.
An interesting but unanswered question is how XBP1s re-
presses the transcription of Wnt10b. Since being identiﬁed as a
mammalian counterpart of yeast Hac1p, XBP1s is known to act
primarily or exclusively as a transcriptional activator [22]. To
our knowledge, our ﬁnding is the ﬁrst evidence suggesting a neg-
ative regulatory function for XBP1 in mammals. Currently, only
two reports provide evidence for transcriptional repression by
XBP1. XBP1 inhibits mesodermal and neural tissue formation in
Xenopus by acting either as transcriptional activator or repressor,
depending upon the binding of cofactors involved in the forma-
tion of distinct transcription complexes [23]. Recently, Jafari
et al. suggested a different mechanism for XBP1-induced tran-
scriptional repression. They suggest that XBP1 differentially regu-
lated the expression of odourant receptors in Drosophila by the
location of the binding motif in the regulatory regions [24].
Although these studies were performed in non-mammalian mod-
el organisms, many reports showing the conservation of UPR [25]
and IRE1-mediated XBP1s generation mechanisms [26], and of
XBP1-binding core sequences [24] during evolution, strongly sug-
gest that XBP1s may also act as a negative regulator in verte-
brates. In this regard, Acosta-Alvear et al. suggested that XBP1
regulates functionally distinct targets possibly through different
sequence motifs and the differential recruitment of accessory fac-
tors [22].
In summary, we showed, for the ﬁrst time, that XBP1s effec-
tively stimulates preadipocyte differentiation by transcriptional
inhibition of Wnt10b and the subsequent decrease of the anti-adi-
pogenic b-catenin signalling pathway. With the known regulatory
function of C/EBPb on Wnt10b and XBP1, our data provide novel
information on the early molecular events during the differentia-
tion of adipocytes.Acknowledgment
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